Results 141 to 150 of about 5,631 (161)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients

open access: yesJournal of Personalized Medicine, 2022
We evaluated switching from brinzolamide 1% or brimonidine 0.1% to a fixed-combination of brinzolamide 1% and brimonidine 0.1%, and then determined the efficacy, safety, and satisfaction associated with these changes in glaucoma patients.
Yoshiaki Kiuchi   +2 more
exaly   +2 more sources

The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients

open access: yesJournal of Clinical Medicine
Objectives: The purpose of this study was to investigate switching from brimonidine and ripasudil, and brimonidine or ripasudil, to a fixed combination of brimonidine and ripasudil, and evaluate the associated efficacy and safety in glaucoma patients ...
Yoshiaki Kiuchi   +2 more
exaly   +2 more sources

Brimonidine (Alphagan®): A Clinical Profile Four Years after Launch

open access: yesEuropean Journal of Ophthalmology, 2001
The early information on the clinical efficacy, safety, and tolerability of brimonidine 0.2% were obtained from studies that compared brimonidine monotherapy with timolol and betaxolol. These studies showed its intra-ocular pressure lowering efficacy to
R. David
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Difference in vasoconstrictors: oxymetazoline vs. brimonidine

Journal of Dermatological Treatment, 2021
Steven R. Feldman, Abigail Cline
exaly  

Adverse effects of brimonidine eye drop in children: A case series

Journal of Clinical Pharmacy and Therapeutics, 2021
Zahra Ghaffari   +2 more
exaly  

Efficacy, safety, and current applications of brimonidine

Expert Opinion on Drug Safety, 2008
L Jay Katz
exaly  

Home - About - Disclaimer - Privacy